A Phase I Dose Intensification Study Using Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable, Non-Small Cell Lung Cancer

Trial Profile

A Phase I Dose Intensification Study Using Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable, Non-Small Cell Lung Cancer

Discontinued
Phase of Trial: Phase I

Latest Information Update: 04 May 2016

At a glance

  • Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 17 Dec 2009 Planned end date changed from 11 Jun 2009 to 11 Jun 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top